Quality of life in patients with atrial fibrillation: a systematic review.

By G. Thrall, D. Lane, D. Carroll, Gregory Y. H. Lip. American Journal of Medicine, 2006

698 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Economics and Econometrics

View Paper: https://www.semanticscholar.org/paper/e2d847bb73607c18f2bf5ba0b4a93bdb9c4b1d3a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, background): “Patients with AF have a significantly poorer quality of life compared with healthy controls, the general population, or patients with coronary heart disease in sinus rhythm.(13) Left ventricular (LV) function is often impaired by the irregular, fast ventricular rate and by loss of atrial contractile”
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “Patients with AF have significantly poorer quality of life than healthy controls, experiencing a variety of symptoms including lethargy, palpitations, dyspnoea, chest tightness, sleeping difficulties, and psychosocial distress.(32,177) – 180 Improved quality of life Table 6 Clinical types of atrial ”
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial (2019, neutral): “Published Online:March 15, 2019. doi:10.1001/jama.2019.0693 Author Affiliations:Mayo Clinic, Rochester, Minnesota (Packer, Robb, Monahan, Noseworthy); Duke Clinical Research Institute, Duke University, Durham, North Carolina (Mark, Bahnson, Piccini, Silverstein, Al-Khalidi, Lee); University of Washi”
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012, result): “Patients with AF, as reflected by standardized SF36 scores, have substantially impaired QOL, below population norms, and comparable to patients with coronary artery disease and congestive heart failure [526, 527, 530].”
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, result): “%) and was associated with a lower rate of unplanned hospitalization.529 Taken as a whole, the results of these studies suggest that catheter ablation of AF is safe and effective in selected patients with HF.”
Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. (2013, background): “However, AF continues to have a significant impact on quality of life [7], morbidity and mortality [8].”
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. (2014, result): “Although studies have demonstrated significantly improved QOL after therapeutic intervention, in general there does not seem to be a significant difference between a management strategy aiming to control ventricular rate and a strategy of rhythm control (ie, interventions to convert AF and maintain ”
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study (2013, neutral): “Turk Kardiyol Dern Ars 2008 June;36(4):214-22.”